Skip to main navigation Skip to search Skip to main content

Therapeutic effect of a novel anilidoquinoline derivative, 2-(2-methyl-quinoline-4ylamino)-N-(2-chlorophenyl)-acetamide, in Japanese encephalitis: correlation with in vitro neuroprotection

  • Joydeep Ghosh
  • , Vivek Swarup
  • , Amit Saxena
  • , Sulagna Das
  • , Abhijit Hazra
  • , Priyankar Paira
  • , Sukdeb Banerjee
  • , Nirup B. Mondal
  • , Anirban Basu

Research output: Contribution to journalArticlepeer-review

Abstract

2-(2-Methyl-quinoline-4ylamino)-N-(2-chlorophenyl)-acetamide, a novel anilidoquinoline derivative, was synthesised and evaluated for its therapeutic efficacy in treating Japanese encephalitis. The compound showed significant antiviral and antiapoptotic effects in vitro. Significant decreases in viral load (P < 0.01) combined with an increase in survival was observed in Japanese encephalitis virus-infected mice treated with 2-(2-methyl-quinoline-4ylamino)-N-(2-chlorophenyl)-acetamide.

Original languageEnglish (US)
Pages (from-to)349-354
Number of pages6
JournalInternational Journal of Antimicrobial Agents
Volume32
Issue number4
DOIs
StatePublished - Oct 2008
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Anilidoquinoline
  • Apoptosis
  • Japanese encephalitis virus
  • Neuron
  • TUNEL

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Therapeutic effect of a novel anilidoquinoline derivative, 2-(2-methyl-quinoline-4ylamino)-N-(2-chlorophenyl)-acetamide, in Japanese encephalitis: correlation with in vitro neuroprotection'. Together they form a unique fingerprint.

Cite this